Toxic Exposures Clinical Trial Award

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The FY24 TERP CTA is intended to support the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. To meet the intent of the award mechanism, applications must address at least one of the FY24 TERP Program Goals and at least one of the FY24 TERP Topic Areas.

Who can apply

  • Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org

Key dates & funding
  • PostedJun 26, 2024
  • ClosesNov 12, 2024
  • Program funding$10,400,000
  • Expected awards3
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro